- ホーム
- > 洋書
- > 英文書
- > Science / Mathematics
Full Description
Role of Nanocarriers in Management of Non-Hodgkin Lymphoma is a pivotal resource that explores the transformative impact of nanotechnology on the diagnosis, treatment, and management of non-Hodgkin's lymphoma (NHL). This comprehensive guide bridges the gap between innovative research and clinical application, focusing on advancements in polymeric nanoparticles, lipid carriers, carbon nanotubes, and immunotherapy approaches. The book provides an in-depth analysis of current technologies and future directions in integrating nanocarriers into NHL management. Each chapter offers evidence-based insights and mechanisms of action, emphasizing the synergy between immunotherapy, precision medicine, and nanotechnology. This resource benefits its academic audience by equipping healthcare professionals with innovative strategies to improve treatment outcomes and inspiring researchers to explore novel therapeutic pathways. By fostering interdisciplinary collaboration among oncologists, pharmaceutical developers, and nanotechnology experts, the book ultimately guides future research to enhance patient care in the rapidly evolving field of non-Hodgkin's lymphoma management.
Contents
1. Introduction to Non-Hodgkin's Disease and Conventional Therapies
2. Immune Checkpoint Inhibitors in Non-Hodgkin's Lymphoma Management
3. Exploring Polymeric Nanoparticles in Non-Hodgkin's Lymphoma Management
4. Magnetic Nanoparticles in Non-Hodgkin's Lymphoma Therapy: Advancements and Future Directions
5. Leveraging Nanostructured Lipid Carrier (NLCs) in Non-Hodgkin's Lymphoma Management
6. Breakthrough in Antibody-Drug Conjugates for Non-Hodgkin's Lymphoma Management
7. Targeted Non-Hodgkin's Lymphoma Management with Carbon Nanotubes: Potential and Progress
8. Advancement in Non-Hodgkin's Lymphoma Management Using Exosomes
9. Biological and Immunological Aspects of Vaccines for Non-Hodgkin's Lymphoma Management
10. Immunotherapy and Radioimmunotherapy Approaches for Non-Hodgkin's Lymphoma Management
11. Innovative mRNA Approach for Non-Hodgkin's Lymphoma Management
12. Monoclonal Antibody and CAR T-Cell Therapy: A Novel Avenue in Non-Hodgkin's Lymphoma Management
13. Combination of Nanocarrier with Chemotherapy for Non-Hodgkin's Lymphoma Management
14. Patient Care in Non-Hodgkin's Lymphoma Management
15. Regulatory Challenges and Approvals for Nanocarrier-Based Therapies
